240 related articles for article (PubMed ID: 26400507)
1. Outcomes of ovarian stimulation after treatment with chemotherapy.
Chan JL; Johnson LN; Efymow BL; Sammel MD; Gracia CR
J Assist Reprod Genet; 2015 Oct; 32(10):1537-45. PubMed ID: 26400507
[TBL] [Abstract][Full Text] [Related]
2. Response to ovarian stimulation in patients facing gonadotoxic therapy.
Johnson LN; Dillon KE; Sammel MD; Efymow BL; Mainigi MA; Dokras A; Gracia CR
Reprod Biomed Online; 2013 Apr; 26(4):337-44. PubMed ID: 23415997
[TBL] [Abstract][Full Text] [Related]
3. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type.
Lefebvre T; Mirallié S; Leperlier F; Reignier A; Barrière P; Fréour T
Reprod Biomed Online; 2018 Aug; 37(2):201-207. PubMed ID: 29784618
[TBL] [Abstract][Full Text] [Related]
4. Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
Quinn MM; Cakmak H; Letourneau JM; Cedars MI; Rosen MP
Hum Reprod; 2017 Mar; 32(3):568-574. PubMed ID: 28122888
[TBL] [Abstract][Full Text] [Related]
5. Change in oocyte yield in repeated in vitro fertilization cycles: effect of ovarian reserve.
Eppsteiner EE; Sparks AE; Liu D; Van Voorhis BJ
Fertil Steril; 2014 Feb; 101(2):399-402. PubMed ID: 24331835
[TBL] [Abstract][Full Text] [Related]
6. Assessment of ovarian reserve by antral follicle count in ovaries with endometrioma.
Lima ML; Martins WP; Coelho Neto MA; Nastri CO; Ferriani RA; Navarro PA
Ultrasound Obstet Gynecol; 2015 Aug; 46(2):239-42. PubMed ID: 25504940
[TBL] [Abstract][Full Text] [Related]
7. Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation.
Tran ND; Aghajanova L; Kao CN; Cedars MI; Rosen MP
Fertil Steril; 2016 Mar; 105(3):690-696. PubMed ID: 26696299
[TBL] [Abstract][Full Text] [Related]
8. Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield.
Letourneau JM; Cakmak H; Quinn M; Sinha N; I Cedars M; Rosen MP
J Assist Reprod Genet; 2017 Sep; 34(9):1137-1144. PubMed ID: 28669055
[TBL] [Abstract][Full Text] [Related]
9. Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome.
Talaulikar VS; Conway GS; Pimblett A; Davies MC
Fertil Steril; 2019 Mar; 111(3):505-509. PubMed ID: 30598170
[TBL] [Abstract][Full Text] [Related]
10. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
Muteshi C; Child T; Ohuma E; Fatum M
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
[TBL] [Abstract][Full Text] [Related]
11. Different stimulation protocols for oocyte cryropreservation in oncological patients: a retrospective analysis of single university centre.
Simi G; Obino ME; Casarosa E; Litta P; Artini PG; Cela V
Gynecol Endocrinol; 2015; 31(12):966-70. PubMed ID: 26370262
[TBL] [Abstract][Full Text] [Related]
12. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
[TBL] [Abstract][Full Text] [Related]
13. Fertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrieved.
Filippi F; Martinelli F; Paffoni A; Reschini M; Raspagliesi F; Somigliana E
J Assist Reprod Genet; 2019 Mar; 36(3):569-578. PubMed ID: 30478807
[TBL] [Abstract][Full Text] [Related]
14. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
15. A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count.
Jayaprakasan K; Hopkisson J; Campbell B; Johnson I; Thornton J; Raine-Fenning N
BJOG; 2010 Jun; 117(7):853-62. PubMed ID: 20353458
[TBL] [Abstract][Full Text] [Related]
16. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
[TBL] [Abstract][Full Text] [Related]
17. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials.
Nelson SM; Klein BM; Arce JC
Fertil Steril; 2015 Apr; 103(4):923-930.e1. PubMed ID: 25624196
[TBL] [Abstract][Full Text] [Related]
18. Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin's lymphoma when compared with breast cancer candidates for fertility preservation.
Sonigo C; Comtet M; Duros S; Sifer C; Sermondade N; Grynberg M
J Assist Reprod Genet; 2018 Jan; 35(1):91-97. PubMed ID: 28986734
[TBL] [Abstract][Full Text] [Related]
19. Random-start ovarian stimulation in patients with cancer.
Cakmak H; Rosen MP
Curr Opin Obstet Gynecol; 2015 Jun; 27(3):215-21. PubMed ID: 25919235
[TBL] [Abstract][Full Text] [Related]
20. Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation.
Almog B; Azem F; Gordon D; Pauzner D; Amit A; Barkan G; Levin I
Fertil Steril; 2012 Oct; 98(4):957-60. PubMed ID: 22763097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]